Establishment Labs Appoints Filippo Caldini as CEO

Establishment Labs Holdings ( (ESTA) ) has issued an update.

On May 6, 2025, Establishment Labs Holdings Inc. appointed Filippo ‘Peter’ Caldini as the Chief Executive Officer, effective May 7, 2025, following an extensive search process. Caldini, who has been serving as the interim CEO since March 2025, will also join the Board of Directors as a Class II director. This leadership change is expected to drive the company’s strategic goals, including achieving EBITDA positive status in 2025 and cash flow positive in 2026, as the company continues to innovate and expand its market presence, particularly with its upcoming launch in the United States.

Spark’s Take on ESTA Stock

According to Spark, TipRanks’ AI Analyst, ESTA is a Neutral.

The overall stock score is weighed down by financial performance challenges, including ongoing losses and negative cash flows. While the U.S. market launch and operational improvements are promising, global demand issues and high cash usage present risks. The technical indicators suggest a bearish outlook, and the negative P/E ratio reflects valuation concerns, leading to a lower overall score.

To see Spark’s full report on ESTA stock, click here.

More about Establishment Labs Holdings

Establishment Labs Holdings Inc. is a global medical device company focused on improving women’s health and wellness, particularly in breast aesthetics and reconstruction. The company offers a wide range of solutions for breast health, aesthetics, and reconstruction across more than 90 countries, with products like the Motiva® devices setting new standards for safety and patient satisfaction.

Average Trading Volume: 607,543

Technical Sentiment Signal: Sell

Current Market Cap: $954.6M

See more data about ESTA stock on TipRanks’ Stock Analysis page.